The Perfect Enemy | Author: Julio Marchi | Page 623
July 27, 2025

Julio Marchi

Technology Scientist, Executive, and Entrepreneur. Specialized in Internet Products Development, Digital Security, and IT Coaching. System Engineer by degree, Musician and Writer by passion. Journalist and Magazines Publisher in a previous life (getting back to it now). Currently hosting the "Julio Marchi Speaks Out Show" on YouTube.

Study finds Pfizer’s antiviral has little or even zero benefit for younger adults, and WHO says BA.5 omicron subvariant accounted for 74% of cases in latest week

Pfizer’s COVID antiviral Paxlovid appears to have little or no benefit for younger adults, although it still reduces the risk...